Article Menu
-
Academic Editor
David Wong
- Subscribe SciFeed
- Recommended Articles
- Related Info Links
-
More by Authors Links
- on DOAJ
- Iwamoto, H.
- Niizeki, T.
- Nagamatsu, H.
- Ueshima, K.
- Nomura, T.
- Kuzuya, T.
- Kasai, K.
- Kooka, Y.
- Hiraoka, A.
- Sugimoto, R.
- Yonezawa, T.
- Ishihara, A.
- Deguchi, A.
- Arai, H.
- Shimose, S.
- Shirono, T.
- Nakano, M.
- Okamura, S.
- Noda, Y.
- Kamachi, N.
- Sakai, M.
- Suzuki, H.
- Aino, H.
- Matsukuma, N.
- Matsugaki, S.
- Ogata, K.
- Yano, Y.
- Ueno, T.
- Kajiwara, M.
- Itano, S.
- Fukuizumi, K.
- Kawano, H.
- Noguchi, K.
- Tanaka, M.
- Yamaguchi, T.
- Kuromatsu, R.
- Kawaguchi, A.
- Koga, H.
- Torimura, T.
- New FP Study Group, .
- Kurume Liver Cancer Study Group of Japan, .
- on Google Scholar
- Iwamoto, H.
- Niizeki, T.
- Nagamatsu, H.
- Ueshima, K.
- Nomura, T.
- Kuzuya, T.
- Kasai, K.
- Kooka, Y.
- Hiraoka, A.
- Sugimoto, R.
- Yonezawa, T.
- Ishihara, A.
- Deguchi, A.
- Arai, H.
- Shimose, S.
- Shirono, T.
- Nakano, M.
- Okamura, S.
- Noda, Y.
- Kamachi, N.
- Sakai, M.
- Suzuki, H.
- Aino, H.
- Matsukuma, N.
- Matsugaki, S.
- Ogata, K.
- Yano, Y.
- Ueno, T.
- Kajiwara, M.
- Itano, S.
- Fukuizumi, K.
- Kawano, H.
- Noguchi, K.
- Tanaka, M.
- Yamaguchi, T.
- Kuromatsu, R.
- Kawaguchi, A.
- Koga, H.
- Torimura, T.
- New FP Study Group, .
- Kurume Liver Cancer Study Group of Japan, .
- on PubMed
- Iwamoto, H.
- Niizeki, T.
- Nagamatsu, H.
- Ueshima, K.
- Nomura, T.
- Kuzuya, T.
- Kasai, K.
- Kooka, Y.
- Hiraoka, A.
- Sugimoto, R.
- Yonezawa, T.
- Ishihara, A.
- Deguchi, A.
- Arai, H.
- Shimose, S.
- Shirono, T.
- Nakano, M.
- Okamura, S.
- Noda, Y.
- Kamachi, N.
- Sakai, M.
- Suzuki, H.
- Aino, H.
- Matsukuma, N.
- Matsugaki, S.
- Ogata, K.
- Yano, Y.
- Ueno, T.
- Kajiwara, M.
- Itano, S.
- Fukuizumi, K.
- Kawano, H.
- Noguchi, K.
- Tanaka, M.
- Yamaguchi, T.
- Kuromatsu, R.
- Kawaguchi, A.
- Koga, H.
- Torimura, T.
- New FP Study Group, .
- Kurume Liver Cancer Study Group of Japan, .
Need Help?
Order Article Reprints
Journal: Cancers, 2021
Volume: 13
Number: 646
646
Article:
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma
Authors:
by
Hideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, Kazuomi Ueshima, Takako Nomura, Teiji Kuzuya, Kazuhiro Kasai, Yohei Kooka, Atsushi Hiraoka, Rie Sugimoto, Takehiro Yonezawa, Akio Ishihara, Akihiro Deguchi, Hirotaka Arai, Shigeo Shimose, Tomotake Shirono, Masahito Nakano, Shusuke Okamura, Yu Noda, Naoki Kamachi, Miwa Sakai, Hiroyuki Suzuki, Hajime Aino, Norito Matsukuma, Satoru Matsugaki, Kei Ogata, Yoichi Yano, Takato Ueno, Masahiko Kajiwara, Satoshi Itano, Kunitaka Fukuizumi, Hiroshi Kawano, Kazunori Noguchi, Masatoshi Tanaka, Taizo Yamaguchi, Ryoko Kuromatsu, Atsushi Kawaguchi, Hironori Koga, Takuji Torimura, New FP Study Group and Kurume Liver Cancer Study Group of Japanadd
Show full author list
remove
Hide full author list
Link:
https://www.mdpi.com/2072-6694/13/4/646
MDPI provides article reprints in high quality with convenient shipping to destinations worldwide. The articles are printed in on premium paper with high-resolution figures. Our covers are customized to your article and designed to be complimentary to the journal. These reprints are ideal additions to your portfolio. Copy details: 135g/m2 paper, 2x stitched, full colour and glossy finish, orderable in quantities from 10 to 1000.
If you have any questions, or special requests, please write to our support team; we are happy to provide you with the information you need.
Cite
Iwamoto, H.; Niizeki, T.; Nagamatsu, H.; Ueshima, K.; Nomura, T.; Kuzuya, T.; Kasai, K.; Kooka, Y.; Hiraoka, A.; Sugimoto, R.; et al. Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma. Cancers 2021, 13, 646. https://doi.org/10.3390/cancers13040646
Iwamoto H, Niizeki T, Nagamatsu H, Ueshima K, Nomura T, Kuzuya T, Kasai K, Kooka Y, Hiraoka A, Sugimoto R, et al. Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma. Cancers. 2021; 13(4):646. https://doi.org/10.3390/cancers13040646
Chicago/Turabian StyleIwamoto, Hideki, Takashi Niizeki, Hiroaki Nagamatsu, Kazuomi Ueshima, Takako Nomura, Teiji Kuzuya, Kazuhiro Kasai, Yohei Kooka, Atsushi Hiraoka, Rie Sugimoto, and et al. 2021. "Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma" Cancers 13, no. 4: 646. https://doi.org/10.3390/cancers13040646
APA StyleIwamoto, H., Niizeki, T., Nagamatsu, H., Ueshima, K., Nomura, T., Kuzuya, T., Kasai, K., Kooka, Y., Hiraoka, A., Sugimoto, R., Yonezawa, T., Ishihara, A., Deguchi, A., Arai, H., Shimose, S., Shirono, T., Nakano, M., Okamura, S., Noda, Y., ... Kurume Liver Cancer Study Group of Japan. (2021). Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma. Cancers, 13(4), 646. https://doi.org/10.3390/cancers13040646
